Skip to content
2000
Volume 28, Issue 7
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Nutriose is a dextrin-based soluble fiber prepared from starch. Cereals such as maize, wheat, and barley are the primary sources of nutrients for commercial production. Nutriose is resistant to digestion by human enzymes in the stomach and small intestine. It is mostly undamaged when it enters the colon after traveling through the digestive tract, where it generates Short-Chain Fatty Acids (SCFAs) as byproducts. These SCFAs, which include butyrate, propionate, and acetate, have a number of health advantages. They foster an environment in the colon that is advantageous for gut health-promoting bacteria like and . Nutriose fermentation leads to a more balanced composition of the gut microbiota, which may have advantages for the immune system, better digestion, and increased nutrient absorption. As a result, nutriose is currently being utilized as a prebiotic. Several publications have previously demonstrated the impact of nutriose on stimulating gut mucosal immunity and boosting colonic fermentation and excretion in rats. Nanoformulations and nutrisomes have already been prepared and evaluated in recent years. A novel nutriose-based polymeric coating mix has already been tested as a potential colon-targeting material. As a natural polysaccharide, nutriose’s possible uses in pharmaceuticals may increase in the near future. The purpose of this study is to critically analyze existing data to determine the potential of nutriose as a natural polymer for various drug delivery systems.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073283113240329064552
2024-04-05
2025-08-18
Loading full text...

Full text loading...

References

  1. SurguchovA. BernalL. SurguchevA.A. Phytochemicals as regulators of genes involved in synucleinopathies.Biomolecules202111562410.3390/biom1105062433922207
    [Google Scholar]
  2. BindelsL.B. DelzenneN.M. CaniP.D. WalterJ. Towards a more comprehensive concept for prebiotics.Nat. Rev. Gastroenterol. Hepatol.201512530331010.1038/nrgastro.2015.4725824997
    [Google Scholar]
  3. Blanco-GarcíaE. Otero-EspinarF.J. Blanco-MéndezJ. Leiro-VidalJ.M. Luzardo-ÁlvarezA. Development and characterization of anti-inflammatory activity of curcumin-loaded biodegradable microspheres with potential use in intestinal inflammatory disorders.Int. J. Pharm.20175181-28610410.1016/j.ijpharm.2016.12.05728040561
    [Google Scholar]
  4. CannyG.O. McCormickB.A. Bacteria in the intestine, helpful residents or enemies from within?Infect. Immun.20087683360337310.1128/IAI.00187‑0818474643
    [Google Scholar]
  5. FarombiE.O. AdedaraI.A. AjayiB.O. AyepolaO.R. EgbemeE.E. Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats.Basic Clin. Pharmacol. Toxicol.20131131495510.1111/bcpt.1205023336970
    [Google Scholar]
  6. FinegoldS.M. Intestinal bacteria. The role they play in normal physiology, pathologic physiology, and infection.Calif. Med.196911064554595789139
    [Google Scholar]
  7. GordonD.T. OkumaK. Determination of total dietary fiber in selected foods containing resistant maltodextrin by enzymatic-gravimetric method and liquid chromatography: Collaborative study.J. AOAC Int.2002852435444
    [Google Scholar]
  8. GrizardD. BarthomeufC. Non-digestible oligosaccharides used as prebiotic agents: Mode of production and beneficial effects on animal and human health.Reprod. Nutr. Dev.1999395-656358810.1051/rnd:1999050510619166
    [Google Scholar]
  9. Guérin-DeremauxL. The health benefits of a soluble fiber: Blood glucose management and colonic ecosystem modulation.Paris, FranceJournée Technique Fibres2018a
    [Google Scholar]
  10. Guérin-DeremauxL. HobdenM.R. ThabuisC. VazhapillyR. MortonK. KalmanD. KennedyO.B. NUTRIOSE®, a soluble fibre with demonstrated benefits for blood glucose management in humans.7th Dietary Fiber conferenceRotterdam, The Netherlands2018
    [Google Scholar]
  11. Guérin-DeremauxL. HobdenM.R. ThabuisC. VazhapillyR. VercruysseA.S. KennedyO.B. The health benefits of a soluble fiber: The soluble fiber NUTRIOSE® attenuates the blood glucose impact of a high carbs intake and displays a prolonged colonic fermentation pattern through gut microbiota modulation in healthy volunteers.Geneva, SwitzerlandVitafood Europe2018
    [Google Scholar]
  12. Guerin-DeremauxL. RingardF. DesaillyF. WilsD. Effects of a soluble dietary fibre NUTRIOSE® on colonic fermentation and excretion rates in rats.Nutr. Res. Pract.20104647047610.4162/nrp.2010.4.6.47021286404
    [Google Scholar]
  13. IvanovI.I. HondaK. Intestinal commensal microbes as immune modulators.Cell Host Microbe201212449650810.1016/j.chom.2012.09.00923084918
    [Google Scholar]
  14. Lefranc-MillotC. NUTRIOSE ® 06: A useful soluble dietary fibre for added nutritional value.Nutr. Bull.200833323423910.1111/j.1467‑3010.2008.00711.x
    [Google Scholar]
  15. Lefranc-MillotC. DeremauxL. RousseauxC. WilsD. Saniez-DegraveM.H. DesreumauxP. Impact of a new resistant dextrin on intestinal well-being and immunity maintenance.Ann. Nutr. Metab.2007511154
    [Google Scholar]
  16. Lefranc-MillotC. Guérin-DeremauxL. WilsD. NeutC. MillerL.E. Saniez-DegraveM.H. Impact of a resistant dextrin on intestinal ecology: How altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health.J. Int. Med. Res.201240121122410.1177/14732300120400012222429361
    [Google Scholar]
  17. MartínA.R. VillegasI. La CasaC. de la LastraC.A. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats.Biochem. Pharmacol.20046771399141010.1016/j.bcp.2003.12.02415013856
    [Google Scholar]
  18. PouillartP.R. DépeintF. AbdelnourA. DeremauxL. VincentO. MazièreJ.C. MadecJ.Y. ChatelainD. YounesH. WilsD. SaniezM.H. DupasJ.L. Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets.Inflamm. Bowel Dis.201016578379410.1002/ibd.2113019998458
    [Google Scholar]
  19. RivièreA. SelakM. LantinD. LeroyF. De VuystL. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut.Front. Microbiol.2016797910.3389/fmicb.2016.0097927446020
    [Google Scholar]
  20. RoturierJ.M. LootenP. NUTRIOSE®: Analytical aspects.Proceedings of the Dietary Fibre ConferenceHelsinki, Finland 200615
    [Google Scholar]
  21. RoturierJ.M. LootenP.H. OstermanE. Dietary fibre measurement in food containing NUTRIOSE® FB by enzymatic-gravimetric-HPLC method.Proc. Dietary Fiber ConferenceHelsinki, Finland 2003
    [Google Scholar]
  22. RozanP. DeremauxL. WilsD. HidalgoS. BissonJ.F. MessaoudiM. SaniezM.H. Food dextrin protects against colonic inflammation and prevents cognitive impairments.Curr. Top. Nutrac. Res.200973
    [Google Scholar]
  23. Guerin-DeremauxL. LiS. PochatM. WilsD. MubasherM. ReiferC. MillerL.E. Effects of NUTRIOSE ® dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men.Int. J. Food Sci. Nutr.201162662863510.3109/09637486.2011.56949221591985
    [Google Scholar]
  24. LiS. Guerin-DeremauxL. PochatM. WilsD. ReiferC. MillerL.E. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: A double-blind, randomized, placebo-controlled study.Appl. Physiol. Nutr. Metab.201035677378210.1139/H10‑07421164548
    [Google Scholar]
  25. Saleh-GhadimiS. DehghanP. SarmadiB. MalekiP. Improvement of sleep by resistant dextrin prebiotic in type 2 diabetic women coincides with attenuation of metabolic endotoxemia: Involvement of gut–brain axis.J. Sci. Food Agric.2022102125229523710.1002/jsfa.1187635306660
    [Google Scholar]
  26. HobdenM.R. Martin-MoralesA. Guérin-DeremauxL. WilsD. CostabileA. WaltonG.E. RowlandI. KennedyO.B. GibsonG.R. In vitro fermentation of NUTRIOSE(®) FB06, a wheat dextrin soluble fibre, in a continuous culture human colonic model system.PLoS One2013810e7712810.1371/journal.pone.007712824204753
    [Google Scholar]
  27. ManzW. AmannR. LudwigW. VancanneytM. SchleiferK.H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment.Microbiology199614251097110610.1099/13500872‑142‑5‑10978704951
    [Google Scholar]
  28. ScheppachW. ChristlS.U. BartramH.P. RichterF. KasperH. Effects of short-chain fatty acids on the inflamed colonic mucosa.Scandin.J. Gastroenterol.199732222535710.1080/00365521.1997.11720719
    [Google Scholar]
  29. GeierM. ButlerR. HowarthG. Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.Int. J. Food Microbiol.2007115111110.1016/j.ijfoodmicro.2006.10.00617137666
    [Google Scholar]
  30. ZhouJ. HegstedM. McCutcheonK.L. KeenanM.J. XiX. RaggioA.M. MartinR.J. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut.Obesity200614468368910.1038/oby.2006.7716741270
    [Google Scholar]
  31. RoberfroidM. GibsonG.R. HoylesL. McCartneyA.L. RastallR. RowlandI. WolversD. WatzlB. SzajewskaH. StahlB. GuarnerF. RespondekF. WhelanK. CoxamV. DaviccoM.J. LéotoingL. WittrantY. DelzenneN.M. CaniP.D. NeyrinckA.M. MeheustA. Prebiotic effects: Metabolic and health benefits.Br. J. Nutr.2010104S22S1S6310.1017/S000711451000336320920376
    [Google Scholar]
  32. PineiroM. AspN.G. ReidG. MacfarlaneS. MorelliL. BrunserO. TuohyK. FAO Technical meeting on prebiotics.J. Clin. Gastroenterol.2008423S156S15910.1097/MCG.0b013e31817f184e18685504
    [Google Scholar]
  33. HobdenM.R. CommaneD.M. Guérin-DeremauxL. WilsD. ThabuisC. Martin-MoralesA. WolframS. DìazA. CollinsS. MoraisI. RowlandI.R. GibsonG.R. KennedyO.B. Impact of dietary supplementation with resistant dextrin (NUTRIOSE®) on satiety, glycaemia, and related endpoints, in healthy adults.Eur. J. Nutr.20216084635464310.1007/s00394‑021‑02618‑934170392
    [Google Scholar]
  34. AliasgharzadehA. DehghanP. GargariB.P. Asghari-JafarabadiM. Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: A randomised controlled clinical trial.Br. J. Nutr.2015113232133010.1017/S000711451400367527028002
    [Google Scholar]
  35. BlundellJ. De GraafC. HulshofT. JebbS. LivingstoneB. LluchA. MelaD. SalahS. SchuringE. Van Der KnaapH. WesterterpM. Appetite control: Methodological aspects of the evaluation of foods.Obes. Rev.201011325127010.1111/j.1467‑789X.2010.00714.x20122136
    [Google Scholar]
  36. BeckB. VillaumeC. DebryG. Clinical aspects of GIP secretion.. Acta diabetologialatina1982191110.1007/BF02581180
    [Google Scholar]
  37. Gholizadeh ShamasbiS. DehganP. Mohammad-Alizadeh CharandabiS. AliasgarzadehA. MirghafourvandM. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: A randomized, triple-blind, controlled, clinical trial.Eur. J. Nutr.201958262964010.1007/s00394‑018‑1648‑729480399
    [Google Scholar]
  38. SperoffL. FritzM.A. Clinical gynecologic endocrinology and infertility.Lippincott Williams & Wilkins2005
    [Google Scholar]
  39. PasmanW. WilsD. SaniezM-H. KardinaalA. Long-term gastrointestinal tolerance of NUTRIOSE®FB in healthy men.Eur. J. Clin. Nutr.20066081024103410.1038/sj.ejcn.160241816482066
    [Google Scholar]
  40. RumessenJ.J. Gudmand-HøyerE. Fructans of chicory: Intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption.Am. J. Clin. Nutr.199868235736410.1093/ajcn/68.2.3579701194
    [Google Scholar]
  41. KimK.A. YooH.H. GuW. YuD.H. JinM.J. ChoiH.L. YuanK. Guerin-DeremauxL. KimD.H. Effect of a soluble prebiotic fiber, NUTRIOSE, on the absorption of ginsenoside Rd in rats orally administered ginseng.J. Ginseng Res.201438320320710.1016/j.jgr.2014.03.00325378995
    [Google Scholar]
  42. WakabayashiC. MurakamiK. HasegawaH. MurataJ. SaikiI. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells.Biochem. Biophys. Res. Commun.1998246372573010.1006/bbrc.1998.86909618279
    [Google Scholar]
  43. JuhelC. TosiniF. SteibM. WilsD. Guerin-DeremauxL. LaironD. CaraL. Cholesterol-lowering effect of non-viscous soluble dietary fiber Nutriose6 in moderately hypercholesterolemic hamsters.Indian J. Exp. Biol.201149321922821452602
    [Google Scholar]
  44. Catalán-LatorreA. Pleguezuelos-VillaM. CastangiaI. MancaM.L. CaddeoC. NácherA. Díez-SalesO. PerisJ.E. PonsR. Escribano-FerrerE. FaddaA.M. ManconiM. Nutriosomes: Prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.Nanoscale20181041957196910.1039/C7NR05929A29319093
    [Google Scholar]
  45. ManconiaM. PendásJ. LedónN. MoreiraT. SinicoC. SasoL. FaddaA.M. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.J. Pharm. Pharmacol.201061442343010.1211/jpp.61.04.000219298687
    [Google Scholar]
  46. KrenzlinS. SiepmannF. WilsD. Guerin-DeremauxL. FlamentM.P. SiepmannJ. Non-coated multiparticulate matrix systems for colon targeting.Drug Dev. Ind. Pharm.201137101150115910.3109/03639045.2011.56221421417601
    [Google Scholar]
  47. AshfordM. FellJ. AttwoodD. SharmaH. WoodheadP. An evaluation of pectin as a carrier for drug targeting to the colon.J. Control. Release199326321322010.1016/0168‑3659(93)90188‑B
    [Google Scholar]
  48. WattsP.J. LllumL. Colonic drug delivery.Drug Dev. Ind. Pharm.199723989391310.3109/03639049709148695
    [Google Scholar]
  49. FriendD.R. New oral delivery systems for treatment of inflammatory bowel disease.Adv. Drug Deliv. Rev.200557224726510.1016/j.addr.2004.08.01115555741
    [Google Scholar]
  50. IbekweV.C. FaddaH.M. McConnellE.L. KhelaM.K. EvansD.F. BasitA.W. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.Pharm. Res.20082581828183510.1007/s11095‑008‑9580‑918465212
    [Google Scholar]
  51. McConnellE.L. FaddaH.M. BasitA.W. Gut instincts: Explorations in intestinal physiology and drug delivery.Int. J. Pharm.2008364221322610.1016/j.ijpharm.2008.05.01218602774
    [Google Scholar]
  52. KarroutY. NeutC. WilsD. SiepmannF. DeremauxL. FlamentM.P. DubreuilL. DesreumauxP. SiepmannJ. Novel polymeric film coatings for colon targeting: Drug release from coated pellets.Eur. J. Pharm. Sci.2009373-442743310.1016/j.ejps.2009.03.01419491034
    [Google Scholar]
  53. HebdenJ.M. BlackshawP.E. PerkinsA.C. WilsonC.G. SpillerR.C. Limited exposure of the healthy distal colon to orally‐dosed formulation is further exaggerated in active left‐sided ulcerative colitis.Aliment. Pharmacol. Ther.200014215516110.1046/j.1365‑2036.2000.00697.x10651655
    [Google Scholar]
  54. Lefranc-MillotC. WilsD. NeutC. Saniez-DegraveM.H. Effects of a soluble fiber, with excellent tolerance, NUTRIOSE® 06, on the gut ecosystem: a review.Dietary Fibre20061214
    [Google Scholar]
  55. McConnellE.L. TutasJ. MohamedM.A.M. BanningD. BasitA.W. Colonic drug delivery using amylose films: The role of aqueous ethylcellulose dispersions in controlling drug release.Cellulose2006141253410.1007/s10570‑006‑9078‑8
    [Google Scholar]
  56. SiewL.F. BasitA.W. NewtonJ.M. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems.AAPS PharmSciTech200013536110.1208/pt01032214727908
    [Google Scholar]
  57. KarroutY. NeutC. WilsD. SiepmannF. DeremauxL. DubreuilL. DesreumauxP. SiepmannJ. Colon targeting with bacteria-sensitive films adapted to the disease state.Eur. J. Pharm. Biopharm.2009731748110.1016/j.ejpb.2009.04.00319406234
    [Google Scholar]
  58. KarroutY. NeutC. WilsD. SiepmannF. DeremauxL. FlamentM.P. DubreuilL. DesreumauxP. SiepmannJ. Enzymatically activated coated multiparticulates containing theophylline for colon targeting.J. Drug Deliv. Sci. Technol.201020319319910.1016/S1773‑2247(10)50029‑7
    [Google Scholar]
  59. MeissnerY. LamprechtA. Alternative drug delivery approaches for the therapy of inflammatory bowel disease.J. Pharm. Sci.20089782878289110.1002/jps.2121617948914
    [Google Scholar]
  60. MaroniA. ZemaL. CereaM. SangalliM.E. Oral pulsatile drug delivery systems.Expert Opin. Drug Deliv.20052585587110.1517/17425247.2.5.85516296783
    [Google Scholar]
  61. WattsP. SmithA. TARGIT™ technology: Coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract.Expert Opin. Drug Deliv.20052115916710.1517/17425247.2.1.15916296742
    [Google Scholar]
  62. SiccardiD. TurnerJ.R. MrsnyR.J. Regulation of intestinal epithelial function: A link between opportunities for macromolecular drug delivery and inflammatory bowel disease.Adv. Drug Deliv. Rev.200557221923510.1016/j.addr.2004.08.00515555739
    [Google Scholar]
  63. SiepmannF. SiepmannJ. WaltherM. MacRaeR.J. BodmeierR. Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size.J. Control. Release2005105322623910.1016/j.jconrel.2005.03.02815946758
    [Google Scholar]
  64. LecomteF. SiepmannJ. WaltherM. MacRaeR.J. BodmeierR. Polymer blends used for the aqueous coating of solid dosage forms: Importance of the type of plasticizer.J. Control. Release200499111310.1016/j.jconrel.2004.05.01115342176
    [Google Scholar]
  65. MittalA. GhoshD.P. SinghP.K. Nutriose-eudragit coated pellets for colon targeted drug delivery: A Novel Approach.Lambert academic publishing20175156
    [Google Scholar]
  66. AhmedI.S. Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon.Drug Dev. Ind. Pharm.2005314-546547010.1080/0363904050021470416093212
    [Google Scholar]
  67. GhaffariA. OskouiM. HelaliK. BayatiK. Rafiee-TehraniM. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: Preparation and evaluation.Acta Pharm.200656329931019831279
    [Google Scholar]
  68. HeW. DuQ. CaoD. XiangB. FanL. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats.Int. J. Pharm.20083481-2354510.1016/j.ijpharm.2007.07.00517697758
    [Google Scholar]
  69. Pramod KumarT.M. Siddaramaiah RaviV. Novel colon targeted drug delivery system using natural polymers.Indian J. Pharm. Sci.200870111111310.4103/0250‑474X.4034620390095
    [Google Scholar]
  70. SureshkumarR. MunikumarM. GaneshG.N.K. JawaharN. NagasamyvenkateshD. SenthilV. RajuL. SamanthaM.K. Formulation and evaluation of pectin-hydroxypropyl methylcellulose coated curcumin pellets for colon delivery.Asian J. Pharm.20093213810.4103/0973‑8398.55052
    [Google Scholar]
  71. Anonymous, EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of a health claim related to “non fermentable” carbohydrates and maintenance of tooth mineralisation by decreasing tooth demineralisation pursuant to Article 13 (5) of Regulation (EC) No 1924/2006.EFSA J.20131173329
    [Google Scholar]
  72. Guerin-DeremauxL. Monograph: The Health Benefits of Nutriose soluble fibre, pp 1-24 , 2019.
    [Google Scholar]
  73. SerreliG. IncaniA. AtzeriA. AngioniA. CampusM. CauliE. ZurruR. DeianaM. Antioxidant effect of natural table olives phenolic extract against oxidative stress and membrane damage in enterocyte‐like cells.J. Food Sci.201782238038510.1111/1750‑3841.1361328071793
    [Google Scholar]
  74. van den HeuvelE.G.H.M. WilsD. PasmanW.J. BakkerM. SaniezM-H. KardinaalA F M. Short-term digestive tolerance of different doses of NUTRIOSE®FB, a food dextrin, in adult men.Eur. J. Clin. Nutr.20045871046105510.1038/sj.ejcn.160193015220947
    [Google Scholar]
  75. VermorelM. CoudrayC. WilsD. SinaudS. TressolJ.C. MontaurierC. VernetJ. BrandoliniM. Bouteloup-DemangeC. RayssiguierY. Energy value of a low-digestible carbohydrate, NUTRIOSE-FB, and its impact on magnesium, calcium and zinc apparent absorption and retention in healthy young men.Eur. J. Nutr.200443634435210.1007/s00394‑004‑0477‑z15309452
    [Google Scholar]
  76. YouQ.Y. HuM.D. QianH. Advanced nanoarchitectonics of drug delivery systems with pyroptosis inhibition for noncancerous disease treatment.Adv. Funct. Mater.2024231519910.1002/adfm.202315199
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073283113240329064552
Loading
/content/journals/cchts/10.2174/0113862073283113240329064552
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): colon targeting; colonic bacterial enzyme; dextrin; Nutriose; polysaccharide; prebiotic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test